Comparative Genomic Analysis of Multi-Drug Resistant IPseudomonas aeruginosa/I Sequence Type 235 Isolated from Sudan

• Published in: Microorganisms (Basel) Vol. 11; no. 6
• Main Authors: Hussain, Mohamed A, Mohamed, Malik Suliman, Altayb, Hisham N, Mohamed, Ahmed Osman, Ashour, Ahmed, Osman, Wadah, Sherif, Asmaa E, Ghazawi, Kholoud F, Miski, Samar F, Ibrahim, Sabrin R. M, Mohamed, Gamal A, Sindi, Ikhlas A, Alshamrani, Ahmad A, Elgaml, Abdelaziz
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.05.2023
• Subjects: Bacterial genetics; Comparative analysis; Drug resistance in microorganisms; Genetic aspects; Pseudomonas aeruginosa; Sudan
• ISSN: 2076-2607; 2076-2607
• DOI: 10.3390/microorganisms11061432

Pseudomonas aeruginosa (P. aeruginosa) is known to be associated with resistance to practically all known antibiotics. This is a cross-sectional, descriptive, laboratory-based analytical study in which 200 P. aeruginosa clinical isolates were involved. The DNA of the most resistant isolate was extracted and its whole genome was sequenced, assembled, annotated, and announced, strain typing was ascribed, and it was subjected to comparative genomic analysis with two susceptible strains. The rate of resistance was 77.89%, 25.13%, 21.61%, 18.09%, 5.53%, and 4.52% for piperacillin, gentamicin, ciprofloxacin, ceftazidime, meropenem, and polymyxin B, respectively. Eighteen percent (36) of the tested isolates exhibited a MDR phenotype. The most MDR strain belonged to epidemic sequence type 235. Comparative genomic analysis of the MDR strain (GenBank: MVDK00000000) with two susceptible strains revealed that the core genes were shared by the three genomes but there were accessory genes that were strain-specific, and this MDR genome had a low CG% (64.6%) content. A prophage sequence and one plasmid were detected in the MDR genome, but amazingly, it contained no resistant genes for drugs with antipseudomonal activity and there was no resistant island. In addition, 67 resistant genes were detected, 19 of them were found only in the MDR genome and 48 genes were efflux pumps, and a novel deleterious point mutation (D87G) was detected in the gyrA gene. The novel deleterious mutation in the gyrA gene (D87G) is a known position behind quinolone resistance. Our findings emphasize the importance of adoption of infection control strategies to prevent dissemination of MDR isolates.